We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Medlab Middle East Rebranded to WHX Labs Dubai

By LabMedica International staff writers
Posted on 06 Feb 2025
Print article
Image: The unveiling of WHX Labs Dubai marks a new era for laboratory innovation (Photo courtesy of Informa Markets)
Image: The unveiling of WHX Labs Dubai marks a new era for laboratory innovation (Photo courtesy of Informa Markets)

Informa Markets (London, UK) has officially announced the rebranding of Medlab Middle East to WHX Labs Dubai, underscoring a transformative vision for connecting people, businesses, governments and innovators across borders. The name World Health Expo (WHX) unifies Informa’s healthcare events around the world to better facilitate connection and collaboration under a single brand.

Medlab Middle East 2025, held at the Dubai World Trade Centre (DWTC) under the theme ‘Empowering today’s medical labs for tomorrow’s future,’ brought together over 800 exhibitors and welcomed more than 20,000 visitors to explore the latest technology and updates for the laboratory industry. The event is showcasing the latest innovations and technologies across eight dynamic product categories, which include Disposables and Consumer Goods, Emergency Medicine, Imaging and Diagnostics, Healthcare and General Services, IT, Laboratory, Medical Equipment and Devices and Pharma and Nutrition. WHX Labs Dubai will build on Medlab Middle East’s 24 years of success, connecting more than half a million healthcare professionals in nine countries across four continents. By consolidating each event within the Informa Markets Healthcare portfolio, WHX aims to amplify their impact, fostering greater innovation, stronger connections and transformative progress within the healthcare ecosystem.

“WHX Labs Dubai represents the evolution of the laboratory industry into a global force for scientific advancement – an exciting future driven by international collaboration, technological breakthroughs, and innovation from around the world,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “This new identity highlights Dubai’s essential role as a hub for laboratory innovation and reinforces the city’s lasting impact on the industry’s advancement. By establishing WHX Labs Dubai, we reaffirm our commitment to driving progress in the sector while honoring Dubai’s dynamic ecosystem, which continues to foster cutting-edge scientific discovery and development.”

Related Links:
Informa Markets

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The test can find tRNA fragments unique to Parkinson’s disease before patients even have symptoms (Photo courtesy of Shutterstock)

Rapid Blood Test Identifies Pre-Symptomatic Patients with Parkinson’s Disease

Currently, no reliable blood test exists for diagnosing Parkinson’s disease. Instead, physicians rely on observing a patient's movements, but this qualitative method has an error rate of 20%-25% and can... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.